The intellectual heart of UC Berkeley, the College of Letters and Science (L&S) is the largest of the university’s 14 colleges and schools and the most prestigious teaching and research unit in the UC system.

The College of Letters & Science stands at the heart of Berkeley’s intellectual preeminence and comprehensive excellence. Our continued leadership in education, research, and public service depends on private philanthropy.

Secondary navigation

You are here

UC files appeal to revive CRISPR patent interference

July 31, 2017

The University of California yesterday filed its opening brief with the U.S. Court of Appeals for the Federal Circuit in Washington, D.C., in support of its appeal of the U.S. Patent Trial and Appeal Board’s (PTAB) decision in the CRISPR-Cas9 interference. UC’s appeal seeks to reverse the PTAB’s decision finding no interference-in-fact between issued patents and an application of the Broad Institute, the Massachusetts Institute of Technology and Harvard on CRISPR-Cas9 gene editing in plant and animal cells and a patent application filed earlier by UC for gene editing in all environments, both cellular and non-cellular.